Abemaciclib + Irinotecan + Temozolomide

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Abemaciclib + Irinotecan + Temozolomide
Treatment and conditionWhere it standsTrials
Abemaciclib + Irinotecan + Temozolomide for neoplasm metastasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Abemaciclib + Irinotecan + Temozolomide for sarcoma, ewingPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1